PharmaEngine, Inc. reported earnings results for the third quarter and nine months ended September 30, 2021. For the third quarter, the company reported sales was TWD 177.13 million compared to TWD 95.67 million a year ago. Net income was TWD 73.15 million compared to TWD 18.39 million a year ago. Basic earnings per share from continuing operations was TWD 0.51 compared to TWD 0.13 a year ago. Diluted earnings per share from continuing operations was TWD 0.51 compared to TWD 0.13 a year ago. Basic earnings per share was TWD 0.51 compared to TWD 0.13 a year ago. Diluted earnings per share was TWD 0.51 compared to TWD 0.13 a year ago. For the nine months, sales was TWD 451.03 million compared to TWD 269.55 million a year ago. Net income was TWD 314.5 million compared to TWD 81.59 million a year ago. Basic earnings per share from continuing operations was TWD 2.17 compared to TWD 0.56 a year ago. Diluted earnings per share from continuing operations was TWD 2.17 compared to TWD 0.56 a year ago. Basic earnings per share was TWD 2.17 compared to TWD 0.56 a year ago. Diluted earnings per share was TWD 2.17 compared to TWD 0.56 a year ago.